Faculty profile
John McGuire
Back to facultyResearch
Read how they describe their research on their Western University profile.
Latest papers
Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.
JCI insight · 2024
A pref-1-controlled non-inflammatory mechanism of insulin resistance.
iScience · 2023
Latest funding
- $975,376
Vascular endothelium-specific PAR2: mechanisms and effects
CIHR · 2022 · Nominated PI
2 publications.
Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.
Huang Y, Chen L, Li L, Qi Y, Tong H, Wu H, Xu J, Leng L, Cheema S, Sun G, Xia Z, McGuire J, Rodrigues B, Young LH, Bucala R, Qi D
A pref-1-controlled non-inflammatory mechanism of insulin resistance.
Huang Y, Cui D, Chen L, Tong H, Wu H, Muller GK, Qi Y, Wang S, Xu J, Gao X, Fifield KE, Wang L, Xia Z, Vanderluit JL, Liu S, Leng L, Sun G, McGuire J, Young LH, Bucala R, Qi D
Vascular endothelium-specific PAR2: mechanisms and effects
Principal investigators: McGuire, John J
Keywords: Blood Pressure; Blood Vessel; Endothelial Cell-Specific Knockout Mouse; Peptides; Protease-Activated Receptor 2; Vascular Endothelium
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Department of Medical Biophysics
- Biomedical Sciences
- Pharmacy
- Genetics
- Cellular and Molecular Pharmacology
Co-authors at Western University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.